• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Intuitive Surgical Could Trade Sideways Before Hitting All-Time Highs

Traders could go long on ISRG here, or wait to buy strength.
By BRUCE KAMICH
Mar 06, 2019 | 09:36 AM EST
Stocks quotes in this article: ISRG

For his "Executive Decision" segment of Mad Money Tuesday night, Jim Cramer sat down to speak with Gary Guthart, CEO of Intuitive Surgical (ISRG) . ISRG is the surgical robotics maker that recently posted a minor earnings miss, but has still seen its shares climb 14% for the year.

Guthart said his company's products help hospitals deliver better outcomes for patients at lower costs. Doctors performed one million procedures using Intuitive's DaVinci robot last year alone and it is growing at 18% annually.

Intuitive's latest robot, called Ion, is expected to be a game changer for lung cancer, Guthart explained, as it allows definitive diagnoses to be performed faster. Guthart said Ion is expected to do well in markets like China, where there is an increase in lung cancer and lung diseases. Cramer added that whenever the broader markets decline, investors should be looking at companies like ISRG. Let's take a look at the charts.

In this daily bar chart of ISRG, below, we see that prices rally strongly -- as they did from early April to late September. During the advance, the rising 50-day moving average line acted as support, and dips toward the line were buying opportunities. The daily On-Balance-Volume (OBV) line rose with the price action and confirmed the rally.

ISRG corrected to the downside in the fourth quarter, but the price movement and the indicators were strong. Prices declined -- but notice how long ISRG stayed above the rising 200-day moving average line. The line was not broken until late December, and then ISRG quickly rallied back over the line.

Now, ISRG is above both the rising 50-day moving average line and the bullish 200-day line. The 50-day average is about to cross above the 200-day line for what is commonly called a golden cross. These crossovers are typically late and viewed as bullish (when back-tested, these crossovers are not all that reliable).

Another positive to point out is the bullish divergence from the On-Balance-Volume (OBV) line -- the line made a double bottom in October and December when prices made a lower low. The same pattern can be seen on the Moving Average Convergence Divergence (MACD) oscillator, which crossed above the zero line in January for an outright buy signal.

In this weekly bar chart of ISRG, below, we can see that patient longs from 2016 have been rewarded. ISRG is above the rising 40-week moving average line. The weekly OBV line is pointed up and the MACD oscillator gave a new buy signal in early February.

In this Point and Figure chart of ISRG, below, we can see the 2018 rally and the fourth-quarter correction. The late February trade at $550.23 was an important upside breakout. A longer-term price target of $681.70 is shown. A trade at $584.08 is needed to refresh the uptrend.

Bottom line strategy: ISRG could trade sideways for a few weeks before attempting a test of the late September/early October zenith. Traders could go long here and wait, if they are okay with risking a close below $515, otherwise wait to buy strength.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Executive Interview

More from Investing

Look for General Motors Shares to Restart Their Uptrend

Bruce Kamich
May 23, 2022 2:10 PM EDT

Why aggressive traders could get behind the GM wheel again.

Alibaba Is Sold out on the Downside

Bruce Kamich
May 23, 2022 1:26 PM EDT

China at a bearish extreme is an opportunity.

It 'Bears' Repeating: Tune Out the Noise!

Bob Lang
May 23, 2022 1:16 PM EDT

The noise around the markets is loud, distracting and sometimes obnoxious, but if you listen to it, you'll end up making poor decisions.

I've Got Smith & Wesson in the Holster, but the Safety Switch Stays On

Jonathan Heller
May 23, 2022 12:30 PM EDT

I wouldn't jump the gun on this name, but here's why I find it compelling.

Dow Is Poised for an Upside Breakout

Bruce Kamich
May 23, 2022 11:25 AM EDT

Here are our price targets.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login